Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases

Author:

Reid Pankti1ORCID,Sandigursky Sabina2,Song Juhee3,Lopez-Olivo Maria A.4,Safa Houssein5,Cytryn Samuel6,Efuni Elizaveta6,Buni Maryam7,Pavlick Anna8,Krogsgaard Michelle9,Abu-Shawer Osama1011,Altan Mehmet12,Weber Jeffrey S.13,Rahma Osama E.101415,Suarez-Almazor Maria E.47,Diab Adi5,Abdel-Wahab Noha5716

Affiliation:

1. Division of Rheumatology, Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA

2. Division of Rheumatology, Department of Medicine, NYU Langone Health, New York, NY, USA

3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

4. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

5. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

6. Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA

7. Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

8. Medical Oncology, Weill Cornell Medical Center, New York, NY, USA

9. Perlmutter Cancer Center, Department of Pathology, NYU Langone Health, New York, NY, USA

10. Department of Internal Medicine, Harvard Medical School, Boston, MA, USA

11. Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA

12. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

13. Perlmutter Cancer Center, Department of Medicine, NYU Langone Health, New York, NY, USA

14. Department of Oncology, Dana Farber Cancer Institute, Boston, MA, USA

15. Internal Medicine, Brigham and Women’s Hospital, Boston, MA, USA

16. Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3